MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: dystonia"

  • MDS Virtual Congress 2020

    Smell and Taste in Blepharospasm

    J. Gamain, T. Herr, T. Hummel, B. Veit, C. Willert, B. Lehnert, R. Fleischmann, A. Stenner, F. Tost, M. Kronenbürger (Greifswald, Germany)

    Objective: To contribute to the better understanding of blepharospasm, we systematically assess olfactory and gustatory ability in subjects with blepharospasm, compared to subjects with cervical…
  • MDS Virtual Congress 2020

    Writer’s cramp: A focal dystonia exacerbated by psychological symptoms

    A. Verghese (Georgetown, Malaysia)

    Objective: Here we retrospectively analysed nineteen patients followed up in our centre, the Neurology Unit of the Penang General Hospital, for writer’s cramp from the…
  • MDS Virtual Congress 2020

    Management of Cervical Dystonia & Spastic Paresis with Botulinum Neurotoxin-A: results from the INPUT survey

    R. Bhidayasiri, L.J Jacinto, K. Bhatia, N. Dursun, T.M Chung, J. Tiley, C. Colosimo (Bangkok, Thailand)

    Objective: To describe current practices among physicians using botulinum toxin-A (BoNT-A) to treat spastic paresis (SP) and cervical dystonia (CD). Background: BoNT-A is an effective…
  • MDS Virtual Congress 2020

    Effects of onabotulinum toxin A on balance and gait in Parkinson’s disease with foot dystonia: A case series study

    P. Huang, YY. Li, P. Huang, Q. Xiao, Y. Wang, S. Chen, S.D Chen, J. Liu, Y.W Wu (Shanghai, China)

    Objective: To investigate the effectiveness of botulinum toxin (BoNT) in reducing the severity of dystonia and improving gait and balance in Parkinson’s disease (PD) patients…
  • MDS Virtual Congress 2020

    Botulinum Toxin dose optimization in pediatric DYT1 type Focal Hand Dystonia and tremor

    A. Lin, K. Set (Dayton, OH, USA)

    Objective: We diagnosed a rare pediatric case of genetic focal hand dystonia (FHD) with dystonic tremor and optimized Onabotulinum Toxin A injection treatment dosing. Background:…
  • MDS Virtual Congress 2020

    Refractory cervical dystonia: is the infiltration of the obliquus capitis inferior muscle a game changer?

    A. Beltrán, F. Rodríguez, J.L Chico García, P. Parra, I. Pareés, J.C Martínez Castrillo, A. Alonso Cánovas, G. Sánchez (Madrid, Spain)

    Objective: To communicate the results of infiltration of obliquus capitis inferior (OCI) muscle in complex cervical dystonia (CD). Background: Treatment of CD with botulinum toxin…
  • MDS Virtual Congress 2020

    Patient experiences of cervical dystonia management with botulinum toxin A: A comparison of US versus European survey findings

    C. Comella, J. Ferreira, M. Azoulai, E. Pain, S. Om (Chicago, IL, USA)

    Objective: Evaluate differences in the botulinum neurotoxin type A (BoNT-A) treatment experience between patients with cervical dystonia (CD) treated in the United States (US) versus…
  • MDS Virtual Congress 2020

    Anatomy-guided injections of Botulinum neurotoxin in neck muscles: how accurate is needle placement?

    A. Kreisler, C. Simonin, A. Degardin, E. Mutez, L. Defebvre (Lille, France)

    Objective: To assess the accuracy of anatomy-guided BoNT injections in cervical muscles. Background: Botulinum neurotoxin (BoNT) is the first line therapy for cervical dystonia; some…
  • MDS Virtual Congress 2020

    The effect of botulinum toxin A on pain associated with cervical dystonia (CD) in routine clinical practice

    R. Trosch, V. Misra, P. Maisonobe, S. Om (Farmington Hills, MI, USA)

    Objective: To evaluate the effect of abobotulinumtoxinA (aboBoNT-A) on pain associated with cervical dystonia (CD) in routine clinical practice. Background: Pain is considered as the…
  • MDS Virtual Congress 2020

    Botolinum Toxin A in a 33-year old Multigravid Filipino with Dystonia Gravidarum: A Case Report

    G. Vista, J. Vatanagul, K. Sia (Cebu, Philippines)

    Objective: This paper aims to present a rare case of dystonia gravidarum using Botolinum Toxin A as treatment. Background: Dystonia is a rare event in…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 21
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley